Compare SPDR Gold Trust (GLD) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SPDR Gold Trust vs Zoetis Inc — how do they compare? SPDR Gold Trust trades at $384.58 (market cap $139.66B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: SPDR Gold Trust is far larger — about 4.6× Zoetis Inc's market cap, and Zoetis Inc pays a 2.9% dividend while SPDR Gold Trust pays none. Which is the better fit depends on your goals — on Pluang, investors hold SPDR Gold Trust for 74 Days and Zoetis Inc for 70 Days on average.
| GLD | ZTS | |
|---|---|---|
Market Cap | $139.66B | $30.20B |
Volume | 9,544,773 | 6,175,327 |
52-Week High | $495.90 | $147.53 |
52-Week Low | $362.32 | $69.09 |
Typical Hold Time | 74 Days | 70 Days |
Sector | — | Health |
Enterprise Value | — | $37.76B |
Dividend Yield | — | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GLD trades at $378.67, up 0.74% with bearish technical signals dominating as 17 indicators signal sell versus 2 buy signals. The stock faces resistance at $380-$384 while finding support at $377-$373. Recent news highlights pressure from rising Treasury yields and dollar strength overwhelming safe-haven demand, with gold failing to sustain gains despite weak employment data.
The outlook remains cautious with technical indicators signaling bearish momentum and fundamental data unavailable. Key risks include persistent rate hike expectations and dollar strength, though some analysts see tactical buying opportunities. Investors should monitor Fed policy decisions and inflation trends for directional catalysts.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SPDR Gold Trust
GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
